Letrozole extended release (Rovi Pharma)
N/A
Report date: 2024/04/09 16:23:16
Base Information
Drug NameLetrozole extended release (Rovi Pharma)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesRovi
China Registration ClassN/A
Develop Information
Active CompaniesRovi Pharmaceuticals Laboratories
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A